Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record.

Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 Patients: National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study

DISMUKES, WILLIAM E., STAMM, ALAN M., GRAYBILL, JOHN R., CRAVEN, PHILIP C., STEVENS, DAVID A., STILLER, ROBERT L., SAROSI, GEORGE A., MEDOFF, GERALD, GREGG, CLARK R., GALLIS, HARRY A., FIELDS, BRANCH T., MARIER, ROBERT L., KERKERING, THOMAS A., KAPLOWITZ, LISA G., CLOUD, GRETCHEN, BOWLES, CYNDI, SHADOMY, SMITH · 1983 · Annals of Internal Medicine

Abstract

The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group. This report emphasizes the toxicity and clinical response data in 52 patients with the following systemic mycoses: blastomycosis in 16 patients; nonmeningeal coccidioidomycosis in 13; histoplasmosis in 8; nonmeningeal cryptococcosis in 7; sporotrichosis in 7; and both blastomycosis and nonmeningeal coccidioidomycosis in 1. Maximum daily doses of ketoconazole were 100 mg in 1 patient; 200 mg in 23; 400 mg in 12; and 600 mg in 16. In 52% of the patients, duration of therapy ranged from less than 1 to 6 months, whereas in 35%, duration ranged from 7 to 12 months, and in 13%, from 12 to 22 months. In 35 patients (67%), evidence of toxicity was not seen. Nausea, anorexia, or vomiting occurred in 21%. Cure or marked improvement was shown in 27 patients (52%), whereas failure of the primary course was seen in 14 (27%) and relapse after ketoconazole was discontinued in 11 (21%). Although this evaluation did not provide clear-cut clinical response data, our results indicate that ketoconazole, in the dosage regimens used, was more effective in patients with histoplasmosis and nonmeningeal cryptococcosis than in patients with blastomycosis and nonmeningeal coccidioidomycosis, and least effective in patients with sporotrichosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-98-1-13

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 189

Metadata

Authors
DISMUKES, W. E., STAMM, A. M., GRAYBILL, J. R., CRAVEN, P. C., STEVENS, D. A., STILLER, R. L., SAROSI, G. A., MEDOFF, G., GREGG, C. R., GALLIS, H. A., FIELDS, B. T., MARIER, R. L., KERKERING, T. A., KAPLOWITZ, L. G., CLOUD, G., BOWLES, C., & SHADOMY, S.
Venue
Annals of Internal Medicine
Published
1983-01-01
Volume
98
Issue
1
Pages
13-20
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2166353565
Cited by
189
References
0
FWCI
21.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 Patients: National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study. https://app.cochat.ai/papers/10.7326/0003-4819-98-1-13
The paper
DISMUKES, W. E., STAMM, A. M., GRAYBILL, J. R., CRAVEN, P. C., STEVENS, D. A., STILLER, R. L., SAROSI, G. A., MEDOFF, G., GREGG, C. R., GALLIS, H. A., FIELDS, B. T., MARIER, R. L., KERKERING, T. A., KAPLOWITZ, L. G., CLOUD, G., BOWLES, C., & SHADOMY, S. (1983). Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 Patients: National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-98-1-13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.